COPD monocytes demonstrate impaired migratory ability

Respiratory Research
Arjun K RaviDave Singh

Abstract

Increased lung macrophage numbers in COPD may arise from upregulation of blood monocyte recruitment into the lungs. CCR5 is a monocyte chemokine receptor regulated by interleukin-6 (IL-6); the concentration of CCR5 ligands are known to be elevated in COPD lungs. The objective of this study was to investigate mechanisms of monocyte recruitment to the lung in COPD, including the role of CCR5 signalling. Ninety one COPD patients, 29 smokers (S) and 37 non-smokers (NS) underwent sputum induction, plasma sampling (to measure IL-6 and soluble IL-6 receptor [sIL-6R] by immunoassay), monocyte characterization (by flow cytometry) and monocyte isolation for cell migration and quantitative polymerase chain reaction studies. Lung tissue was used for immunohistochemistry. Plasma IL-6 and sIL-6R levels were increased in COPD. Greater proportions of COPD CD14++CD16+ monocytes expressed CCR5 compared to controls. Monocyte stimulation with IL-6 and sIL-6R increased CCR5 gene expression. COPD monocytes demonstrated impaired migration towards sputum supernatant compared to NS (% migration, 4.4 vs 11.5, respectively; p < 0.05). Pulmonary microvessels showed reduced monocyte recruitment (% marginated cells) in COPD compared to NS, (9.3% vs 83.1%, r...Continue Reading

References

Jan 1, 1988·Virchows Archiv. B, Cell Pathology Including Molecular Pathology·N BraunH K Müller-Hermelink
Oct 1, 1996·American Journal of Respiratory and Critical Care Medicine·I RahmanW MacNee
Oct 1, 1996·The European Respiratory Journal·S GonzálezJ C Hogg
Sep 18, 1999·The European Respiratory Journal·A CapelliC F Donner
Jan 27, 2000·Journal of Leukocyte Biology·C WenischW Hörl
Mar 16, 2000·Proceedings of the National Academy of Sciences of the United States of America·A SaccaniA Sica
May 16, 2000·Journal of Leukocyte Biology·C WeberH W Ziegler-Heitbrock
Jul 27, 2000·The New England Journal of Medicine·P J Barnes
May 23, 2002·American Journal of Respiratory and Critical Care Medicine·Marina SaettaLeonardo M Fabbri
Sep 3, 2002·American Journal of Respiratory and Critical Care Medicine·Katsuyuki TomitaIan M Adcock
Oct 18, 2002·Arthritis and Rheumatism·Norikuni KawanakaHirofumi Makino
May 15, 2003·Mediators of Inflammation·Geneviève LehouxMarek Rola-Pleszczynski
Jun 24, 2004·Infection and Immunity·Víctor AsensiJosé Manuel Arribas
Jun 25, 2004·The New England Journal of Medicine·James C HoggPeter D Paré
Sep 2, 2005·The European Respiratory Journal·J WangerG Viegi
Sep 24, 2005·American Journal of Respiratory and Critical Care Medicine·John R HurstJadwiga A Wedzicha
Oct 20, 2005·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Marc P PusztaszeriFred T Bosman
Oct 21, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Nadina StadlerJohannes Waltenberger
Oct 11, 2007·Chest·Claudia CostaLouise E Donnelly
Jul 22, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ceri A FieldingBrendan J Jenkins
Aug 30, 2008·Clinical and Experimental Immunology·L J C SmythD Singh
Aug 19, 2009·European Heart Journal·Kyrill S RogacevGunnar H Heine
Oct 27, 2009·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Risa K Benwell, David R Lee
Sep 14, 2011·Respiration; International Review of Thoracic Diseases·M BafadhelC E Brightling
May 25, 2012·PloS One·Alvar AgustíUNKNOWN Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators
Mar 19, 2013·Respiratory Research·Jun KojimaKazuyoshi Kuwano
Feb 19, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yanhui CaiMarcelo J Kuroda
Sep 4, 2014·Respiratory Research·Arjun K RaviDave Singh
Dec 4, 2014·Nature·Elisa Gomez PerdigueroHans-Reimer Rodewald
Nov 10, 2015·American Journal of Respiratory and Critical Care Medicine·A Nicole DeschClaudia V Jakubzick
Mar 12, 2016·The European Respiratory Journal·Claudia CostaLouise E Donnelly
Jun 23, 2016·Thorax·Ibon Eguíluz-GraciaEspen S Baekkevold
Jan 28, 2017·American Journal of Respiratory and Critical Care Medicine·Claus F VogelmeierAlvar Agustí

❮ Previous
Next ❯

Citations

Jun 9, 2019·International Journal of Molecular Sciences·Pauline HenrotIsabelle Dupin
May 10, 2019·F1000Research·Alice E JasperGeorgia M Walton
Sep 24, 2019·Frontiers in Immunology·Theodore S KapellosJoachim L Schultze
Aug 1, 2019·Respiratory Research·Amit R AgarwalSundeep Salvi
Apr 1, 2019·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Jürgen KnoblochAndrea Koch
Feb 6, 2020·International Journal of Molecular Sciences·Kentaro Akata, Stephan F van Eeden
Aug 5, 2017·Scientific Reports·Jennifer A DewhurstDave Singh
Mar 6, 2021·Journal of Clinical Immunology·Bert Malengier-DevliesCarine Wouters
Apr 4, 2021·International Journal of Molecular Sciences·Bijean D FordRabindra Tirouvanziam
Apr 26, 2021·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Nami Shrestha PalikheHarissios Vliagoftis

❮ Previous
Next ❯

Methods Mentioned

BETA
bronchoalveolar lavage
surgical resection
FACS

Software Mentioned

GraphPad Prism
SPSS Statistics

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

CFTR Mutant Structural Therapy

Over 1700 different mutations in the CFTR genes have been shown to cause cystic fibrosis. Here is the latest research on structural therapy for CFTR mutants.